Buscar
Mostrando ítems 1-10 de 15
Sequential treatment with monofluorophosphate and zoledronic acid in osteoporotic rats
(Taylor & Francis Ltd, 2014-08)
Objective Osteoporosis is the consequence of an imbalance in bone remodeling caused by excessive resorption or inappropriate bone formation. This paper proposes a sequential treatment with monofl uorophosphate (MFP) and ...
Zoledronate repositioning as a potential trypanocidal drug: Trypanosoma cruzi HPRT an alternative target to be considered
(Pergamon-Elsevier Science Ltd, 2021-06)
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and affects 7 million people worldwide. Considering the side effects and drug resistance shown by current treatments, the development of new anti-Chagas ...
Crystal structure and magnetic properties of two new zoledronate complexes: A Mn dimer [Mn(II)(H3Zol)2·(H2O)2] and a Fe15 molecular cluster [Fe(III)15(HZol)10(H2Zol)2 (H2O)12(Cl4:(H2O)2)·Cl7·(H2O)65] (where H4Zol: C5H10N2O7P2 is zoledronic acid)
(Elsevier Science Sa, 2013-01)
The synthesis, X-ray structure and magnetic properties of two new zoledronato complexes are presented: Mn(II)(H3Zol)2(H 2O)2, (I) and Fe(III)15(HZol) 10(H2Zol)2 (H2O)24 (2/3Cl:1/3H2O)6·7Cl·65(H2O) (II), where H4Zol = ...
Zoledronic acid effect on bone of growing ratsEfecto del acido zoledrónico en el hueso de ratas en crecimiento
(Asociación Argentina de Osteología y Metabolismo Mineral, 2018-12)
Zoledronic acid (ZA) is an antiresorptive drug used in children with bone diseases like osteogenesis imperfecta, juvenil osteoporosis, fibrous dysplasia and primary bone tumors. The aim of the present study was to evaluate ...
Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: A network meta-analysis
(Oxford University Press, 2019)
Background: Osteoporosis and osteopenia are associated with increased fracture incidence in postmenopausal women. We aimed to determine the comparative effectiveness of various available pharmacological therapies. Methods: ...
How Do Bisphosphonates Inhibit Bone Metastasis In Vivo?
(Elsevier, 2010)
Concordancia de la utilización de teriparatide o ácido zoledrónico en pacientes con osteoporosis con recomendaciones internacionales, en una empresa de salud de ColombiaConcordance in the use of teriparatide or zoledronic acid in patients with osteoporosis with international recommendations, in a health company of Colombia
(Universidad Industrial de SantanderPromoción y Prevención FarmacéuticaBucaramanga, Colombia, 2021)
Aminobisphosphonate‐treated ewes as a model of osteonecrosis of the jaw and of dental implant failure
(American Academy of Periodontology, 2020-05)
Background: Bisphosphonate (BP)-related osteonecrosis of the jaw (BRONJ) and dental implant failure are two negative side effects of chronic aminoBP treatment. Methods: Eleven ovariectomized (OVX) ewes and four ewes subjected ...
Successful fibrin-rich plasma (frp) therapy and titanium plate for treating bone defect caused by bisphosphonates related osteonecrosis: a case reportPlasma rico en fibrina (PRF) y placa de titanio en el tratamiento exitoso de un defecto óseo asociado a osteonecrosis causado por bisfosfonatos: reporte de caso
(Universidad Central del Ecuador, 2019)
Desarrollo de un modelo experimental de osteonecrosis de mand`íbula asociada al tratamiento crónico de amnobisfosfonatos.Experimental model of osteonecrosis of the jaw associated to chronic treatment with aminobisphosphonates
(Asociación Argentina de Osteoporosis y Metabolismo Mineral, 2017-05)
La osteonecrosis de mandíbula asociada a aminobisfosfonatos constituye un efecto secundario del tratamiento crónico con los más potentes. Un modelo experimental permitiría determinar la patogenia de dicha alteración. La ...